These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32707116)

  • 1. Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study.
    Sävendahl L; Cooke R; Tidblad A; Beckers D; Butler G; Cianfarani S; Clayton P; Coste J; Hokken-Koelega ACS; Kiess W; Kuehni CE; Albertsson-Wikland K; Deodati A; Ecosse E; Gausche R; Giacomozzi C; Konrad D; Landier F; Pfaeffle R; Sommer G; Thomas M; Tollerfield S; Zandwijken GRJ; Carel JC; Swerdlow AJ
    Lancet Diabetes Endocrinol; 2020 Aug; 8(8):683-692. PubMed ID: 32707116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.
    Sävendahl L; Maes M; Albertsson-Wikland K; Borgström B; Carel JC; Henrard S; Speybroeck N; Thomas M; Zandwijken G; Hokken-Koelega A
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E213-7. PubMed ID: 22238393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.
    Carel JC; Ecosse E; Landier F; Meguellati-Hakkas D; Kaguelidou F; Rey G; Coste J
    J Clin Endocrinol Metab; 2012 Feb; 97(2):416-25. PubMed ID: 22238382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.
    Swerdlow AJ; Cooke R; Albertsson-Wikland K; Borgström B; Butler G; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Gausche R; Giacomozzi C; Kiess W; Hokken-Koelega AC; Kuehni CE; Landier F; Maes M; Mullis PE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tollerfield S; Zandwijken GR; Carel JC
    Horm Res Paediatr; 2015; 84(3):172-83. PubMed ID: 26227295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency.
    Berglund A; Gravholt CH; Olsen MS; Christiansen JS; Stochholm K
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):677-83. PubMed ID: 26147754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity.
    Tidblad A; Bottai M; Kieler H; Albertsson-Wikland K; Sävendahl L
    JAMA Pediatr; 2021 Feb; 175(2):e205199. PubMed ID: 33346824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
    Swerdlow AJ; Cooke R; Beckers D; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Flück CE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Zandwijken GRJ
    J Clin Endocrinol Metab; 2019 Mar; 104(3):658-664. PubMed ID: 30137467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study.
    Pfäffle R; Bidlingmaier M; Kreitschmann-Andermahr I; Land C; Partsch CJ; Schwab KO; Sommer H; Backeljauw P; Kanumakala S; Loche S; Zouater H; Strasburger CJ
    Horm Res Paediatr; 2020; 93(3):154-163. PubMed ID: 32814319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in Children Receiving Growth Hormone Treatment of Growth Disorders: Data From the Genetics and Neuroendocrinology of Short Stature International Study.
    Quigley CA; Child CJ; Zimmermann AG; Rosenfeld RG; Robison LL; Blum WF
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3195-3205. PubMed ID: 28575299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER.
    Sävendahl L; Polak M; Backeljauw P; Blair JC; Miller BS; Rohrer TR; Hokken-Koelega A; Pietropoli A; Kelepouris N; Ross J
    J Clin Endocrinol Metab; 2021 May; 106(6):1728-1741. PubMed ID: 33571362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics.
    Albertsson-Wikland K; Mårtensson A; Sävendahl L; Niklasson A; Bang P; Dahlgren J; Gustafsson J; Kriström B; Norgren S; Pehrsson NG; Odén A
    J Clin Endocrinol Metab; 2016 May; 101(5):2149-59. PubMed ID: 26918292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.
    Swerdlow AJ; Cooke R; Beckers D; Borgström B; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Gausche R; Giacomozzi C; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Mullis PE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Van Eycken L; Zandwijken GRJ
    J Clin Endocrinol Metab; 2017 May; 102(5):1661-1672. PubMed ID: 28187225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of long-term growth hormone therapy in Japanese patients with adult growth hormone deficiency: a postmarketing, multicenter, observational study.
    Shimatsu A; Ishii H; Nishinaga H; Murai O; Chihara K
    Endocr J; 2017 Jul; 64(7):651-662. PubMed ID: 28529275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and cancer incidence among patients treated with recombinant growth hormone during childhood in Israel.
    Libruder C; Blumenfeld O; Dichtiar R; Laron Z; Zadik Z; Shohat T; Afek A
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):813-818. PubMed ID: 27292870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of recombinant human growth hormone in treating children with growth hormone deficiency and idiopathic short stature.
    Chang S; Hui P
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):123-6. PubMed ID: 21529437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-Related Quality of Life of Young Adults Treated with Recombinant Human Growth Hormone during Childhood.
    Sommer G; Gianinazzi ME; Kuonen R; Bohlius J; l'Allemand D; Hauschild M; Mullis PE; Kuehni CE;
    PLoS One; 2015; 10(10):e0140944. PubMed ID: 26474398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors and carotid intima media thickness in young adults born small for gestational age after cessation of growth hormone treatment: a 5-year longitudinal study.
    van der Steen M; Kerkhof GF; Smeets CCJ; Hokken-Koelega ACS
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):975-985. PubMed ID: 29102566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of diabetes among children treated with growth hormone in Israel.
    Lutski M; Zucker I; Zadik Z; Libruder C; Blumenfeld O; Shohat T; Laron Z
    Diabet Med; 2019 Oct; 36(10):1276-1281. PubMed ID: 30690790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short term growth hormone therapy in adult growth hormone deficiency.
    Dutta P; Bhansali A; Ajith Kumar BV; Sharma R; Jaggi S; Bhadada S
    J Assoc Physicians India; 2010 Nov; 58():670-3. PubMed ID: 21510459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.